These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 14555868)

  • 21. Enhancing the efficacy of antidepressants with psychotherapy.
    Petersen TJ
    J Psychopharmacol; 2006 May; 20(3 Suppl):19-28. PubMed ID: 16644768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of adjunctive antidepressant therapy with quetiapine on clinical outcome, quality of sleep and daytime motor activity in patients with treatment-resistant depression.
    Baune BT; Caliskan S; Todder D
    Hum Psychopharmacol; 2007 Jan; 22(1):1-9. PubMed ID: 17191266
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adherence to continuation and maintenance antidepressant use in recurrent depression.
    ten Doesschate MC; Bockting CL; Schene AH
    J Affect Disord; 2009 May; 115(1-2):167-70. PubMed ID: 18760488
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 5-HT7 receptor antagonists as a new class of antidepressants.
    Mnie-Filali O; Lambás-Señas L; Zimmer L; Haddjeri N
    Drug News Perspect; 2007 Dec; 20(10):613-8. PubMed ID: 18301795
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modafinil augmentation in depressed patients with partial response to antidepressants: a pilot study on self-reported symptoms covered by the Major Depression Inventory (MDI) and the Symptom Checklist (SCL-92).
    Rasmussen NA; Schrøder P; Olsen LR; Brødsgaard M; Undén M; Bech P
    Nord J Psychiatry; 2005; 59(3):173-8. PubMed ID: 16208839
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The relationship of guideline-concordant depression treatment and patient adherence to oral diabetes medications.
    Nau DP; Chao J; Aikens JE
    Res Social Adm Pharm; 2005 Sep; 1(3):378-88. PubMed ID: 17138485
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heat-shock protein-70 genes and response to antidepressants in major depression.
    Pae CU; Mandelli L; Serretti A; Patkar AA; Kim JJ; Lee CU; Lee SJ; Lee C; De Ronchi D; Paik IH
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1006-11. PubMed ID: 17428599
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mediating roles of adherence attitude and patient education on antidepressant use in patients with depression.
    Sun GC; Hsu MC; Moyle W; Lin MF; Creedy D; Venturato L
    Perspect Psychiatr Care; 2011 Jan; 47(1):13-22. PubMed ID: 21418069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of antidepressants in a psychiatric emergency department.
    Brodsky L; Pieczynski B
    J Clin Psychopharmacol; 1985 Feb; 5(1):35-8. PubMed ID: 3973069
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Symptom relief and facilitation of emotional processing.
    Goodwin GM
    Eur Neuropsychopharmacol; 2011 Sep; 21 Suppl 4():S710-5. PubMed ID: 21865015
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neurofeedback-enhanced gamma brainwaves from the prefrontal cortical region of meditators and non-meditators and associated subjective experiences.
    Rubik B
    J Altern Complement Med; 2011 Feb; 17(2):109-15. PubMed ID: 21303197
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antidepressants plus exercise an antidote to depression.
    Duke Med Health News; 2006 Nov; 12(11):4. PubMed ID: 17228394
    [No Abstract]   [Full Text] [Related]  

  • 33. Loving-kindness meditation's effects on nitric oxide and perceived well-being: a pilot study in experienced and inexperienced meditators.
    Kemper KJ; Powell D; Helms CC; Kim-Shapiro DB
    Explore (NY); 2015; 11(1):32-9. PubMed ID: 25457445
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A study of structure of phenomenology of consciousness in meditative and non-meditative states.
    Venkatesh S; Raju TR; Shivani Y; Tompkins G; Meti BL
    Indian J Physiol Pharmacol; 1997 Apr; 41(2):149-53. PubMed ID: 9142560
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adverse effects of meditation: a preliminary investigation of long-term meditators.
    Shapiro DH
    Int J Psychosom; 1992; 39(1-4):62-7. PubMed ID: 1428622
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of meditation on respiratory system, cardiovascular system and lipid profile.
    Vyas R; Dikshit N
    Indian J Physiol Pharmacol; 2002 Oct; 46(4):487-91. PubMed ID: 12683226
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment with antidepressants increases insulin-like growth factor-I in cerebrospinal fluid.
    Schilling C; Blum WF; Heuser I; Paslakis G; Wudy SA; Deuschle M
    J Clin Psychopharmacol; 2011 Jun; 31(3):390-2. PubMed ID: 21532371
    [No Abstract]   [Full Text] [Related]  

  • 38. Evidence of new-onset depression among persons with migraine after discontinuing antidepressants.
    Kious BM; Bakian AV
    Psychiatry Res; 2020 Jun; 288():112990. PubMed ID: 32353695
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Oxford Questionnaire on the Emotional Side-effects of Antidepressants (OQuESA): development, validity, reliability and sensitivity to change.
    Price J; Cole V; Doll H; Goodwin GM
    J Affect Disord; 2012 Sep; 140(1):66-74. PubMed ID: 22387055
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Electrocortical activity prior to unpredictable stimuli in meditators and nonmeditators.
    Radin DI; Vieten C; Michel L; Delorme A
    Explore (NY); 2011; 7(5):286-99. PubMed ID: 21907152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.